Share
USER HOTLINE: call us at +49 30 65499 145 | Not all products are available in the USA.
News & Media

Events

  • Hamburg, Germany
    15 February 2025 - 17 February 2025
    DGTHG - Tagung 2025
  • Online
    26 February 2025
    Besonderheiten extrakorporaler Verfahren
  • Bcakground showing Edinburgh
    Edinburgh International Conference Centre
    16 March 2025 - 18 March 2025
    SCTS Annual Meeting 2025
  • Brussels, Belgium
    18 March 2025 - 21 March 2025
    44th ISICEM
  • Online
    30 April 2025
    Nutzen, Zusatznutzen und Potential im Kontext des SGB V
  • Online
    25 June 2025
    Der Grundsatz der evidenzbasierten Medizin
CytoSorbents

Voices around the world

world map
Critical Care
Dr. Yatin Mehta
India, Gurgaon

CytoSorb is indicated for use in conditions where elevated levels of cytokine and/or bilirubin and/or myoglobin exist.

Critical Care
Dr. Tobias Hübner
Switzerland, Münsterlingen

The reason for us to use CytoSorb in the ICU was the lack of treatment options. We never had anything in sepsis, and CytoSorb® is the new star on the horizon.

Cardiovascular
Dr. Endre Nemeth
Hungary, Budapest

Intraoperative hemoadsorption associated with better hemodynamics, lower post-op AKI and RRT, stable bilirubin, and shorter mechanical ventilation time and ICU